Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 First Peer-Reviewed Preclinical and Early Phase 1 Results for NKTR-118 (oral PEG-naloxol) to be Presented at Upcoming Pharmacology and Pain Management Meetings Jul 26, 2007 Nektar to Announce Second Quarter 2007 Financial Results on Wednesday, August 8, 2007, After the Close of U.S. Financial Markets Jul 25, 2007 Nektar Therapeutics President and CEO Howard Robin to Present at Bank of America 2007 Health Care Conference May 25, 2007 Nektar Announces New Organizational Structure and Spending Reduction Initiatives to Solidify the Company's Leadership Position in PEGylation and Pulmonary Drug Development May 23, 2007 CORRECTING and REPLACING Nektar Announces New Organizational Structure and Spending Reduction Initiatives to Solidify the Company's Leadership Position in PEGylation and Pulmonary Drug Development May 23, 2007 Nektar Threraputics Announces Phase 2a Clinical Results Regarding the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative Hospital-Acquired Pneumonia Presented at the Annual American Thoracic Society International Conference May 21, 2007 Clinical Trial Data (Phase 2a) Regarding Inhaled Amikacin Will Be Presented at American Thoracic Society International Conference May 09, 2007 Nektar Therapeutics Announces First Quarter 2007 Results May 09, 2007 Nektar Executives Participating In Upcoming Investor Conferences Apr 27, 2007 Nektar to Announce First Quarter 2007 Financial Results On Wednesday, May 9, 2007, After the Close of U.S. Financial Markets Apr 24, 2007 Pagination First page « first Previous page ‹ previous … Page 47 Page 48 Page 49 Page 50 Current page 51 Page 52 Page 53 Page 54 Page 55 … Next page next › Last page last »